no key · no human

BioSpace API, RSS and sitemap

Every article BioSpace publishes, as JSON, through an open API with no key and no signup. 8,162 of their articles are indexed right now, refreshed hourly.

United StatesEnglisheng#961 by volume

Four ways to pull biospace.com

All four are ours, all four are live, and none of them needs a key.

JSON Search this publisher

Every article we hold from biospace.com, newest first. Add q= to search inside.

curl -s "https://freenewsapi.ai/v1/search?host=www.biospace.com&size=20"open it →

RSS Subscribe in any reader

The same articles as an RSS 2.0 feed. Works in Feedly, Inoreader, Thunderbird — anywhere.

curl -s "https://freenewsapi.ai/v1/rss?host=www.biospace.com&size=50"open it →

JSON Feed For apps

JSON Feed 1.1, the same content in a format apps parse natively.

curl -s "https://freenewsapi.ai/v1/feed.json?host=www.biospace.com&size=50"open it →

Trimmed For agents

Only the fields an agent needs — title, url, date, language — so the response stays small.

curl -s "https://freenewsapi.ai/v1/search?host=www.biospace.com&size=20&fields=title,url,published_at,lang"open it →

What this outlet covers, by share of its recent output:

health 42%business 16%society 11%science 9%

Call the API

A live request. Paste it into a terminal and BioSpace headlines come back as JSON.

bash
curl "https://freenewsapi.ai/v1/search?host=www.biospace.com&size=5"
8,162
articles indexed
3,070
in the last 30 days
131
median per day
2
languages
110 min
median crawl lag
24.07 → 22.10
archive depth

Publishing volume

Articles per day over the last 69 days. The busiest hour is 13:00 UTC — that is when the newsroom pushes its main batch.

2026-07-24: 106 articles2026-07-27: gap in the upstream archive, the whole corpus dips2026-07-28: gap in the upstream archive, the whole corpus dips2026-07-29: 160 articles2026-07-30: gap in the upstream archive, the whole corpus dips2026-07-31: gap in the upstream archive, the whole corpus dips2026-08-03: gap in the upstream archive, the whole corpus dips2026-08-04: gap in the upstream archive, the whole corpus dips2026-08-05: gap in the upstream archive, the whole corpus dips2026-08-06: gap in the upstream archive, the whole corpus dips2026-08-10: gap in the upstream archive, the whole corpus dips2026-08-11: gap in the upstream archive, the whole corpus dips2026-08-12: gap in the upstream archive, the whole corpus dips2026-08-13: gap in the upstream archive, the whole corpus dips2026-08-14: gap in the upstream archive, the whole corpus dips2026-08-17: gap in the upstream archive, the whole corpus dips2026-08-18: gap in the upstream archive, the whole corpus dips2026-08-19: gap in the upstream archive, the whole corpus dips2026-08-20: gap in the upstream archive, the whole corpus dips2026-08-21: gap in the upstream archive, the whole corpus dips2026-08-24: gap in the upstream archive, the whole corpus dips2026-08-25: 109 articles2026-08-26: 91 articles2026-08-27: 117 articles2026-08-28: 90 articles2026-08-31: 92 articles2026-09-01: 180 articles2026-09-02: 183 articles2026-09-03: 160 articles2026-09-04: 102 articles2026-09-06: 2 articles2026-09-07: 42 articles2026-09-08: 216 articles2026-09-09: 173 articles2026-09-10: 156 articles2026-09-11: 131 articles2026-09-14: 140 articles2026-09-15: 150 articles2026-09-16: 106 articles2026-09-17: 150 articles2026-09-18: 42 articles2026-09-20: 15 articles2026-09-21: 102 articles2026-09-22: 130 articles2026-09-23: 165 articles2026-09-24: 118 articles2026-09-25: 48 articles2026-09-27: 23 articles2026-09-28: 115 articles2026-09-29: 188 articles2026-09-30: 131 articles2026-10-01: 177 articles2026-10-02: 50 articles2026-10-03: 10 articles2026-10-04: 10 articles2026-10-05: 193 articles2026-10-06: 131 articles2026-10-07: 196 articles2026-10-08: 124 articles2026-10-09: 95 articles2026-10-12: 147 articles2026-10-13: 118 articles2026-10-14: 143 articles2026-10-15: 159 articles2026-10-16: 115 articles2026-10-19: 179 articles2026-10-20: 139 articles2026-10-21: 155 articles2026-10-22: 141 articles07-2408-2609-0909-2310-0510-2010-22

The 19 hatched days are gaps in the upstream news archive, not quiet days at BioSpace: the whole corpus dips on those dates. They are excluded from the median above.

bash
curl "https://freenewsapi.ai/v1/stats?host=www.biospace.com&top=10"

Publishing rhythm

When BioSpace actually publishes, by hour of day (UTC) and by day of week — measured from 8,162 timestamps, not from a schedule they advertise.

00: 3320001: 9500102: 4470203: 4260304: 2770405: 1370506: 1630607: 2010708: 1860809: 5090910: 3591011: 4581112: 8281213: 1,6551314: 4931415: 1121516: 481617: 351718: 281819: 361920: 532021: 2102122: 872223: 13223
Mon: 1,492MonTue: 1,872TueWed: 1,901WedThu: 1,784ThuFri: 1,053FriSat: 10SatSun: 50Sun

Sections

Sections come from the publisher's own markup, present on 98% of their articles.

Languages

CodeLanguageArticlesShare
enEnglish6,40678.5%
engeng1,75621.5%

Latest articles

The 18 most recent BioSpace articles in the index — the same rows the API returns, rendered for humans.

PreveCeutical Closes Initial Tranche of Non-Brokered Private Placement
2026-10-22 22:31 UTC · Press Releases · Annalee Armstrong
Vancouver, British Columbia--(Newsfile Corp. - October 22, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), i
ESMO 2026: Merck, Moderna shares fall as cancer vaccine disappoints after data leak
2026-10-22 21:04 UTC · Drug Development, News · Annalee Armstrong
A combination of the personalized cancer vaccine intismeran autogene and Merck's Keytruda just barely cleared analysts’ expectations for recurrence-free survival, leaving
AbbVie’s skin disease drug lessens abscess burden in Phase 3 but falls below expectations
2026-10-22 19:48 UTC · Drug Development, News · Gabrielle Masson
AbbVie is eyeing regulatory filings in 2027 for the skin disease drug lutikizumab after clearing multiple endpoints in a late-stage trial, but the results have disappoint
Envoy Medical Announces Reverse Stock Split
2026-10-22 18:55 UTC · Press Releases · Heather McKenzie
White Bear Lake, Minnesota--(Newsfile Corp. - October 22, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health and neuroprosthe
€3 million European programme backs Atrogi's first-in-class drug in FSHD and other muscle-wasting diseases
2026-10-22 18:38 UTC · Press Releases · Heather McKenzie
The oral drug reduced DUX4 in FSHD patient muscle cells and increased lean mass and muscle power in a human study
Biohaven shares pop as FDA accepts resubmission for ataxia drug with adcomm expected
2026-10-22 15:35 UTC · Drug Development, News · Heather McKenzie
Troriluzole, in development for spinocerebellar ataxia, was rejected nearly a year ago when the FDA took issue with the design of Biohaven’s registrational study. The age
DuPont Launches AmberChrom™ SIL Silica Gel for Chromatography to Advance Manufacturing of GLP-1 and Other Peptide Therap
2026-10-22 15:11 UTC · Press Releases · Heather McKenzie
New silica-based chromatography media helps biopharmaceutical manufacturers achieve demanding purity targets while supporting integrated purification workflows from crude
Cepheid Earns Three 2026 IMV ServiceTrak™ Clinical Laboratory Awards for Customer Satisfaction, Service, and System Perf
2026-10-22 15:10 UTC · Press Releases · Heather McKenzie
New recognition at IDWeek reflects independent feedback from clinical laboratory professionals and Cepheid's commitment to delivering A Better Way SUNNYVALE, Calif., Oct.
AbbVie Announces Topline Results from the Phase 3 INTREPID Trial Showing Lutikizumab Significantly Improved Signs and Sy
2026-10-22 15:10 UTC · Press Releases · Heather McKenzie
- In the Phase 3 INTREPID study, lutikizumab achieved the primary endpoint of Hidradenitis Suppurativa Clinical Response 75 (HiSCR75) at Week 16 compared with placebo1 -
Granata Bio Completes Screening in Phase III GRACE Study of GB-hMG
2026-10-22 15:09 UTC · Press Releases · Heather McKenzie
Pivotal IVF study advances into pregnancy follow-up, with the first GRACE baby expected by year-end BOSTON, Oct. 22, 2026 /PRNewswire/ -- Granata Bio Corporation, a bioph
Tax incentives
2026-10-22 15:09 UTC
News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Insights Jobs C
Foundation Medicine Appoints Chadi Nabhan, M.D., MBA, as Chief Medical Officer
2026-10-22 15:08 UTC · Press Releases · Heather McKenzie
BOSTON--(BUSINESS WIRE)--Foundation Medicine, Inc., a global, patient-focused precision medicine company, today announced the appointment of Chadi Nabhan, M.D., MBA, as c
Antogen Opens Oklahoma City Laboratory, Expands Commercial Operations
2026-10-22 15:07 UTC · Press Releases · Heather McKenzie
OKLAHOMA CITY--(BUSINESS WIRE)--Antogen, Inc., a biotechnology company pioneering next-generation personalized diagnostics through immunopeptidomics, today announced that
Daiichi Sankyo Highlights Ongoing Progress Across Industry-Leading ADC Portfolio with New Research Updates at ESMO
2026-10-22 15:07 UTC · Press Releases · Heather McKenzie
- New data from six landmark trials reinforce practice-changing results of Enhertu and Datroway across a broad spectrum of patients in breast and lung cancer - Additional
United Therapeutics Corporation Announces Additional $2 Billion Share Repurchase Authorization
2026-10-22 15:06 UTC · Press Releases · Heather McKenzie
SILVER SPRING, M.D. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that th
Myriad Genetics Releases New MONSTAR-SCREEN-3 Data Demonstrating the Potential of Ultra-Sensitive MRD Detection in Color
2026-10-22 15:05 UTC · Press Releases · Heather McKenzie
Data from ongoing study supports the potential clinical utility of whole-genome sequencing-based Precise MRD™ to identify recurrence risk and detect disease earlier follo
BeOne Medicines to Announce Third Quarter 2026 Financial Results on November 5
2026-10-22 14:58 UTC · Press Releases · Heather McKenzie
SAN CARLOS, Calif.--(BUSINESS WIRE)--$ONC #BeOne--BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, will report its third quarter 2
Paradigm Therapeutics, Inc. Announces First Patient Enrolled in Phase 3 Trial for SD-101 (Zorblesia™) in Epidermolysis B
2026-10-22 14:56 UTC · Press Releases · Heather McKenzie
SD-101 (Zorblesia™) is the First Topical Therapy Being Developed to Treat Wounds and Lesions Across the Entire Skin Surface in Patients with Three Major Subtypes of Epide

Harvest it all

Page through the archive by date. from and to accept YYYY-MM-DD or relative values such as now-7d.

bash
curl "https://freenewsapi.ai/v1/search?host=www.biospace.com&from=now-7d&size=100"

To poll for new material, keep the timestamp of the newest article you saw and ask only for what came after it:

bash
curl "https://freenewsapi.ai/v1/search?host=www.biospace.com&from=now-1h&sort=date_asc"

Article bodies come with full_text=true. No key, no quota tier, no header — see the search endpoint for every parameter.

Metadata quality

How well BioSpace marks up its own pages — useful if you are deciding whether to parse them yourself.

78%
dates from JSON-LD
78%
articles with a byline
98%
articles with sections
193 KB
average page weight

Crawl lag — the delay between publication and the article reaching this index — is 110 min at the median, 469 minutes at the 90th percentile.

Similar publishers

Comparable outlets in the same language. Those without a page here yet link straight to their slice of the API.

FAQ

Does BioSpace have an official API?

Not a public one. This endpoint is the practical alternative: their articles as structured JSON, with title, lead, publication time, section, byline and a link back to the original.

How do I get their RSS feed?

Most publishers expose one at /rss or /feed, but feeds carry only the last few dozen items and drop them within hours. This index keeps 8,162 of their articles and lets you filter by date, language and section.

How many articles does BioSpace publish per day?

131 on a median day, measured across 69 days.

Can I use this commercially?

The API is free and unauthenticated. What you may do with the content is between you and the publisher: we return metadata, a lead paragraph and a link, not a licence.